EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association Between Serum PADI‐4 Levels and Disease Activity in Ulcerative Colitis Patients

Semiha Şimşek, Elvan Işık iD, Betül Çiğdem Yortanlı iD, Cem Çekiç

Gastroenterology Research and Practice · 2026-01 · 2026 (1)

DOI: 10.1155/grp/8211063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastroenterology Research and Practice, online erschienen am 06.04.2026. Verfasst von Semiha Şimşek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Konya City Hospital, Konya, Türkiye. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

PADI‐4 is a member of the peptidyl arginine deiminase enzyme family. This enzyme is expressed by inflammatory cells and plays an important role in inflammation and immune responses. In this study, we aimed to evaluate serum PADI‐4 levels in patients with ulcerative colitis (UC) and to investigate the relationship between PADI‐4 and disease activity. Material and Method Fifty‐one patients with UC and 31 healthy controls were included in this observational study. First, serum PADI‐4 levels in patients with UC and the control group were compared. Subsequently, serum PADI‐4 levels were analyzed in UC patients with active disease and those who are in remission, separately. Finally, the impact of PADI‐4 on predicting disease activity was evaluated by performing correlation analyses between serum PADI‐4 and C‐reactive protein (CRP) in addition to the total Mayo score (TMS) and modified Mayo Endoscopic Subscore (MESS).

Results

Serum mean PADI‐4 levels were found to be significantly higher in the UC group (1317 ± 818 pg/mL) compared to the control group (873 ± 622 pg/mL) ( p : 0.009). Serum mean PADI‐4 levels were significantly different between the three groups (patients with remission, mild disease, and moderate/severe disease group) ( p : 0.015) (1076 ± 609, 1073 ± 683, and 1802 ± 943 pg/mL, respectively). In Spearman′s correlation analysis, it was determined that there was a positive and significant relationship between PADI‐4 and CRP levels ( r = 0.31, p : 0.027) in addition to TMS ( r = 0.419, p : 0.02) and MESS ( r = 0.417, p : 0.002). The ideal serum PADI‐4 levels for predicting disease activity were found to be 980 pg/mL.

Conclusion

Our study revealed that serum PADI‐4 levels were higher in patients with UC compared to healthy controls and might be an effective marker to determine disease severity.

Schlagwörter

Stichwörter der Autor:innen

disease activitypeptidyl arginine deiminase-4ulcerative colitis

Autor:innen und Institutionen

  • Department of Internal Medicine, Konya City Hospital, Konya, Türkiye.
  • Department of Gastroenterology, Ege University School of Medicine, Izmir, Türkiye, ege.edu.tr.
  • Department of Gastroenterology, Tınaztepe University, Izmir, Türkiye.

ORCID-Profile: Elvan Işık, Betül Çiğdem Yortanlı

Zitieren

APA

Şimşek, S., Işık, E., Yortanlı, B. Ç., & Çekiç, C. (2026). Association Between Serum PADI‐4 Levels and Disease Activity in Ulcerative Colitis Patients. Gastroenterology Research and Practice, 2026(1). https://doi.org/10.1155/grp/8211063

Vancouver

Şimşek S, Işık E, Yortanlı BÇ, Çekiç C. Association Between Serum PADI‐4 Levels and Disease Activity in Ulcerative Colitis Patients. Gastroenterology Research and Practice. 2026;2026(1). doi:10.1155/grp/8211063

BibTeX
@article{imek2026,
  author = {Şimşek, Semiha and Işık, Elvan and Yortanlı, Betül Çiğdem and Çekiç, Cem},
  title = {Association Between Serum PADI‐4 Levels and Disease Activity in Ulcerative Colitis Patients},
  journal = {Gastroenterology Research and Practice},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/grp/8211063}
}
Kostenlos starten →